Smartphone-based heart rhythm monitoring from home can reduce same-day cancellations and help save significant health care resources ahead of planned electrical cardioversion in patients with atrial ...

A small series provides provocative new data on the safety of performing direct current cardioversion (DCCV) without oral anticoagulation in high-risk patients with a Watchman left atrial appendage ...

The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

LISBON, Portugal—Patients presenting to the emergency department (ED) with new, symptomatic A-fib do not necessarily need to undergo immediate cardioversion, as is now common practice, the RACE 7 ...

Demonstrating one potential application of the technology, an automated algorithm tied to the KardiaBand wearable ECG (AliveCor) performed “reasonably well” at detecting A-fib in patients scheduled ...

The choice between rhythm and rate control strategy represents one of the most intriguing dilemmas in the management of atrial fibrillation (AF). Although the advantage of rhythm over rate control in ...

Pharmacological- and electrical-first cardioversion worked similarly well for treating acute atrial fibrillation (Afib) in the emergency department, according to the Canadian RAFF2 trial. The 204 ...

A study published in The Lancet found that two ways of quickly restoring normal heart rhythm in patients with acute atrial fibrillation in the emergency department are equally safe and effective. The ...

For 2.3 million Americans whose hearts beat too fast or don't keep a regular rhythm, the answer is usually medicines and occasional electric shocks. But these can cause serious side effects and lose ...

MILAN, ITALY — New research has shed light on a mechanism other than multiple infarcts that may contribute to the association between between atrial fibrillation (AF) and decreased brain function [1].

Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...